课题基金 / 基金详情

Diversity Supplement to Project 1

Diversity Supplement to Project 1
项目 1 的多样性补充
批准号:
8377380
负责人:
Maria Virginia Pascual
金额:
$8.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2014-04-30

项目摘要

项目成果

Maria Virginia Pascual的其他基金

相似基金

相关文献

中文摘要
翻译
我们建议创建一个自身免疫卓越中心,该中心将结合临床医生的努力, 人类免疫学家(包括基础免疫学家和翻译免疫学家)、具有临床专业知识和研究的内科科学家 具有自身免疫学、生物信息学家和老年组学/系统生物学家的经验。团结在一起,集结在一起 集团在临床试验方面拥有广泛的背景,并在合并基础和临床方面有良好的业绩记录 科学。这个团队致力于将创新的治疗方法从实验室的工作台带到他们的 病人的床边。在这种协作环境下,提出了一种系统生物学方法来关注这两个问题 儿童和成人自身免疫性疾病。 该中心的目标是: 1)评估新的靶向治疗的有效性,2)开发简单和强大的生物标志物,使用 最新的基因组方法,3)了解最近发现的T细胞亚群在 疾病发病机制,以及4)评估儿童和成人自身免疫中的抗原特异性反应 疾病。 这些项目将有助于更好地了解特定自身免疫性疾病的发病机制 使我们能够开发一种策略,基于新的转录标记和 以识别自身抗原特异的免疫反应。 该中心将提供: 1)针对牛皮癣和皮肌炎的特定细胞因子的创新临床试验。 2)皮肌炎、银屑病、狼疮和多发性硬化症的生物标志物的开发。 3)寻找治疗皮肌炎的新靶点。 4)开发检测自身抗原特异性免疫反应的方法。 5)开发独特的人类自身免疫性疾病微阵列数据库。
英文摘要
We propose to create an Autoimmunity Center of Excellence that will incorporate the efforts of clinicians, human immunologists (both basic and translational), physician-scientists with clinical expertise and research experience in autoimmunity, bioinformaticians, and geriomics/systems biologists. Together, the assembled group has an extensive background in clinical trials and a proven track record for merging basic and clinical science. This team is committed to bringing innovative treatments from the laboratory bench to their patients' bedside. Within this collaborative setting, a systems biology approach is proposed to focus on both pediatric and adult autoimmune diseases. The goals of the Center are: 1) To assess the efficacy of novel targeted therapies, 2) To develop simple and robust biomarkers using state-of-the-art genomic approaches, 3) To understand the role of recently identified T cell subsets in disease pathogenesis, and 4) To assess antigen-specific responses in pediatric and adult autoimmune diseases. These projects will provide a better understanding of the pathogenesis of specific autoimmune diseases and allow us to develop a strategy to assess disease activity based on novel transcriptional markers as well as to identify autoantigen-specific immune responses. The Center will deliver: 1) Innovative clinical trials targeting specific cytokines in psoriasis & dermatomyositis. 2) Development of biomarkers for dermatomyositis, psoriasis, lupus and multiple sclerosis. 3) Identification of novel therapeutic targets in dermatomyositis. 4) Development of assays to test autoantigen-specific immune responses. 5) Development of a unique microarray database of human autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2
Project 2
Early life respiratory viral infections shape immune development trajectories
Early life respiratory viral infections shape immune development trajectories
海外基金